1-3 of 3
Hyman Muss, MD
Close
Sort by
Journal Articles

A Retrospective Study on Prephase Therapy Prior to Definitive Multiagent Chemotherapy in Aggressive Lymphomas

Luis E Malpica Castillo, MD, Jonathan Galeotti, MD MS, Natalie S Grover, MD, Xianming Tan, PhD, Stephen Clark, PharmD, Hyman Muss, MD, Christopher Dittus, DO
Journal: Blood
Blood (2018) 132 (Supplement 1): 2981.
https://doi.org/10.1182/blood-2018-99-116672
Published: 2018
Journal Articles

A Dose-Finding Study of Lenalidomide As Post-Remission Therapy for Older Adults with Acute Myeloid Leukemia (AML)

Matthew C. Foster, MD, Hendrik W. Van Deventer, MD, Katarzyna Jamieson, MD, Benjamin G. Vincent, MD, Melissa Matson, AGPCNP-BC, Karen McKinnon, PhD, Shannon Reisdorf, BS, Jack Zhang, RN, Will Pulley, BA, Hyman Muss, MD, Anastasia Ivanova, PhD, Joshua F Zeidner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2631.
https://doi.org/10.1182/blood.V130.Suppl_1.2631.2631
Published: 2017
Journal Articles

Toxicities and Related Outcomes of Elderly Patients (pts) (≥65 Years) with Hematologic Malignancies in the Contemporary Era (Alliance A151611)

Michael Tallarico, MD, Jared Foster, PhD, Drew Seisler, PhD, Jacqueline Lafky, PhD, Arti Hurria, Aminah Jatoi, MD, Harvey Jay Cohen, MD, Hyman Muss, MD, Nancy L Bartlett, MD, Bruce Cheson, MD, Sin-Ho Jung, PhD, John C. Byrd, MD, John P. Leonard, MD, Chadi Nabhan, MD MBA, FACP
Journal: Blood
Blood (2016) 128 (22): 536.
https://doi.org/10.1182/blood.V128.22.536.536
Published: 2016